Circulating MiR-133a as a biomarker predicts cardiac hypertrophy in chronic hemodialysis patients

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Wen, Ping ^a   Song, Dan ^b   Ye, Hong ^a   Wu, Xiaochun ^a   Jiang, Lei ^a   Tang, Bing ^a   Zhou, Yang ^a   Fang, Li ^a   Cao, Hongdi ^a   He, Weichun ^a   Yang, Yafang ^a   Dai, Chunsun ^a   Yang, Junwei ^a  

^a THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 133A; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE HYPERTROPHY; HEMODIALYSIS PATIENT; HUMAN; INTERVENTRICULAR SEPTUM THICKNESS; LEFT VENTRICULAR MASS INDEX; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PREDICTION; RNA ANALYSIS; RNA ISOLATION; BLOOD; CARDIOMEGALY; COMPLICATION; ECHOGRAPHY; GENETICS; HEART VENTRICLE; KIDNEY FAILURE, CHRONIC; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RENAL REPLACEMENT THERAPY; STATISTICAL MODEL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARDIOMEGALY; FEMALE; HEART VENTRICLES; HUMANS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MAGNETIC RESONANCE IMAGING; MALE; MICRORNAS; MIDDLE AGED; RENAL DIALYSIS; TROPONIN I; TROPONIN T;

EID: 84908101960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103079     Document Type: Article

References (28)

1. Middleton RJ, Parfrey PS, Foley RN (2001) Left ventricular hypertrophy in the renal patient. J Am Soc Nephrol 12: 1079-1084.
2. Levin A, Djurdjev O, Thompson C, Barrett B, Ethier J, et al. (2005) Canadian randomized trial of hemoglobin maintenance to prevent or delay left ventricular mass growth in patients with CKD. Am J Kidney Dis 46: 799-811.
3. Silberberg JS, Barre PE, Prichard SS, Sniderman AD (1989) Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 36: 286-290.
4. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, et al. (2004) Left ventricular mass monitoring in the follow-up of dialysis patients: prognostic value of left ventricular hypertrophy progression. Kidney Int 65: 1492-1498.
5. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP (1990) Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566.
6. Stewart GA, Foster J, Cowan M, Rooney E, McDonagh T, et al. (1999) Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 56: 2248-2253.
7. Truong QA, Ptaszek LM, Charipar EM, Taylor C, Fontes JD, et al. (2010) Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the Rule Out Myocardial Infarction Using Computer Assisted Tomography trial. J Hypertens 28: 1959-1967.
8. Jakubovic BD, Wald R, Goldstein MB, Leong-Poi H, Yuen DA, et al. (2013) Comparative assessment of 2-dimensional echocardiography vs cardiac magnetic resonance imaging in measuring left ventricular mass in patients with and without end-stage renal disease. Can J Cardiol 29: 384-390.
9. Petrovic D, Obrenovic R, Stojimirovic B (2008) Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. Clin Lab 54: 145-152.
10. Strand AH, Gudmundsdottir H, Fossum E, Os I, Bjornerheim R, et al. (2007) Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years. J Clin Hypertens (Greenwich) 9: 365-371.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
12. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, et al. (2010) Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 31: 2765-2773.
13. Cheng Y, Tan N, Yang J, Liu X, Cao X, et al. (2010) A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond) 119: 87-95.
14. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, et al. (2010) Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 3: 499-506.
15. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, et al. (2010) MiR423-5p as a circulating biomarker for heart failure. Circ Res 106: 1035-1039.
16. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, et al. (2010) Circulating microRNAs in patients with coronary artery disease. Circ Res 107: 677-684.
17. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA- 133 controls cardiac hypertrophy. Nat Med 13: 613-618.
18. Devereux RB, Reichek N (1977) Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618.
19. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
20. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
21. Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-233.
22. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666.
23. Gidlof O, Andersson P, van der Pals J, Gotberg M, Erlinge D (2011) Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology 118: 217-226.
24. Eitel I, Adams V, Dieterich P, Fuernau G, de Waha S, et al. (2012) Relation of circulating MicroRNA-133a concentrations with myocardial damage and clinical prognosis in ST-elevation myocardial infarction. Am Heart J 164: 706-714.
25. Martino F, Lorenzen J, Schmidt J, Schmidt M, Broll M, et al. (2012) Circulating microRNAs are not eliminated by hemodialysis. PLoS One 7: e38269.
26. Wang H, Peng W, Ouyang X, Dai Y (2012) Reduced circulating miR-15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis. Ren Fail 34: 685-690.
27. Emilian C, Goretti E, Prospert F, Pouthier D, Duhoux P, et al. (2012) MicroRNAs in patients on chronic hemodialysis (MINOS study). Clin J Am Soc Nephrol 7: 619-623.
28. Lorenzen JM, Thum T (2012) Circulating and urinary microRNAs in kidney disease. Clin J Am Soc Nephrol 7: 1528-1533.